Dr Jad WAKIM

Faculté de médecine

Chargé d'enseignement

(+961) 1 421 000 ext 71911411 jad.wakim2@usj.edu.lb

Dr Jad Wakim is a Hematologist-Oncologist trained at the University of Texas Southwestern its NCI-designated Comprehensive Cancer Center. He is double American Board Certified in Medical Oncology Hematology. Dr. Wakim was the Director of Sweetwater Cancer Center in Rock Springs, WY for 5 years, affiliated with the Huntsman Cancer Institute, before moving back to his native Lebanon where he joined Hotel-Dieu de France University Hospital Clemenceau Medical Center Affiliated with John Hopkins International. He is a lecturer at the University of Utah Saint Joseph University Faculty of Medicine. He has earned numerous awards for clinical achievements and presentations, and has published many papers and book chapters

DiplômeUniversitéPaysAnnée
American Board of Medical OncologyABIM/ABMS (American Board of Medical Specialties)Etats-Unis2012
American Board of HematologyABIM/ABMS (American Board of Medical Specialties)Etats-Unis2012
Hematology-Oncology FellowshipUniversity of Texas Southwestern Medical CenterEtats-Unis2012
Internal Medicine Chief ResidencySUNY Upstate Medical UniversityEtats-Unis2009
Internal Medicine ResidencySUNY Upstate Medical UniversityEtats-Unis2008
American Board of Internal MedicineABIM (American Board of Internal Medicine)Etats-Unis2008
MDUniversité Saint-Joseph de BeyrouthLiban2004

Enseignement universitaire hors USJPaysEtablissementDate débutDate fin
Internal Medicine & Hematology-Oncology Clinical Instructor, University of Utah, Huntsman Cancer InstituteEtats-UnisUniversity of Utah, Huntsman Cancer Institute01/03/201530/06/2018
Internal Medicine Chief Resident, SUNY Upstate Medical University HospitalEtats-UnisSUNY Upstate Medical University Hospital01/07/200830/06/2009

Expérience professionnelleOrganisationDate débutDate fin
Hematologist-Oncologist, Northern Light Health-Eastern Maine Medical Center, Bangor, ME, USANorthern Light Health-Eastern Maine Medical Center, Bangor, ME01/01/202230/09/2024
Hematologist-Oncologist, St Michael Hospital Cancer Center, Texarkana, TX, USASt Michael Hospital Cancer Center, Texarkana, TX, USA07/01/202130/06/2022
Hematologist-Oncologist, Hotel-Dieu de France University HospitalHotel-Dieu de France University Hospital01/04/201811/11/2024
Hematologist-Oncologist, Clemenceau Medical CenterClemenceau Medical Center01/10/201711/11/2024
Medical Director, Hematologist-Oncologist, Sweetwater Regional Cancer Center, an Affiliate of Huntsman Cancer Institute, University of Utah, NCI-Designated Comprehensive Cancer CenterSweetwater Regional Cancer Center, an Affiliate of Huntsman Cancer Institute, University of Utah, NCI-Designated Comprehensive Cancer Center01/08/201230/09/2017

Médecine et Santé

Targeted Therapies Immunotherapy: Neuro, ENT, Breast, Gynecological, Pulmonary, Digestive, Urinary, Sarcomas, Dermatology, Benign Malignant Hematology

Genetic markers of chronic lymphocytic leukemia: a retrospective study of 312 patients from a reference center in Lebanon. Future Oncology 2023 Sep19(29):1991-2002. Perceptions of the COVID-19 vaccine among patients with cancer: a single-institution survey. Future Oncology 2021 Nov 17(31):4071-4079. Helou S., Helou E., Abou-Khalil V., Wakim J., et al. The effect of the COVID-19 pandemic on physicians’ use perception of telehealth: The case of Lebanon. Int. J. Environ. Res. Public Health 2020, 17, 4866 Chaudary P., Wakim J., Khadim H., Karumbaiah KK., Gajra A. Acquired factor X deficiency in systemic amyloidosis: management of two cases. Haemophilia, 2013 Nov 19(6): e375-6. Wakim JJ., Levenson BM., Matthews D., Naina H. Management of an unusual case of intravascular large B-cell lymphoma of the penis, prostate, bones with CNS relapse. Journal of Clinical Oncology, 2013 June 1031(17):e288-9. Wakim JJ., Tirado CA., Dowell J., and Chen W. The first case of Philadelphia-negative acute promyelocytic leukemia following imatinib for chronic myeloid leukemia. Cancer Genetics and Cytogenetics, 2012 March;205(3): p124-127. Wakim JJ. and Tirado CA (January 2012). Acute promyelocytic leukemia lacking the classic translocation t(15;17). In: Koschmieder, S. and Krug, U. (Editors). Myeloid Leukemia – Clinical Diagnosis and Treatment. Chapter 12, p219-234. Intech. Wakim JJ., Tirado CA., Chen W., and Collins R. t(8;22)/BCR-FGFR1 myeloproliferative disorder presenting as B-acute lymphoblastic leukemia: report of a case treated with sorafenib and review of the literature. Leukemia Research, 2011 Sep;35(9):e151-3